773 Pill — ORANGE OVAL, 17mm — Sitagliptin

773 pill photo
View full Sitagliptin profile
Imprint773
ColourORANGE
ShapeOVAL
Size17
StrengthSITAGLIPTIN PHOSPHATE 100 mg;SIMVASTATIN 40 mg
Dosage formTablet, Film Coated
ManufacturerMerck Sharp & Dohme Corp.
NDC0006-0773
Schedule—
Availability—
IngredientsSITAGLIPTIN PHOSPHATE[SITAGLIPTIN];SIMVASTATIN[SIMVASTATIN]

What does this imprint mean?

The imprint "773" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Sitagliptin

Uses and warnings

Pancreatitis - "postmarketing reports of acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis"; Heart Failure - association observed with DPP-4 inhibitors in cardiovascular trials; Acute Renal Failure - "postmarketing reports of worsening renal function, including acute renal failure"; Hypoglycemia risk increased when combined with insulin or insulin secretagogues; Hypersensitivity Reactions including anaphylaxis, angioedema, Stevens-Johnson syndrome; Arthralgia - severe joint pain reported with DPP-4 inhibitors; Bullous Pemphigoid, a blistering condition requiring hospitalization.

"JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus." Not for type 1 diabetes or patients with pancreatitis history.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Sitagliptin

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file c41b4a12-6504-4fe8-abbe-e7f3ba0d28e2.xml